Literature DB >> 19475500

The utility of genetic counseling prior to offering first trimester screening options.

L Brent Hafen1, Rebecca S Hulinsky, Sara Ellis Simonsen, Stephanie Wilder, Nancy C Rose.   

Abstract

In order to evaluate the utility of genetic counseling at the time of first trimester screening in patients with no previously identified genetic concerns, we reviewed family history data for 700 women seen for genetic counseling in Utah during 2005-2006. The mean maternal age was 35 years (Range: 16-47 years). The majority of patients seen were non-Jewish Caucasians (90.8%, 634/700). A three-generation pedigree was obtained from each woman by one of two certified genetic counselors and subsequently classified as "negative" (no birth defects/genetic disorders); "positive" (birth defect or genetic condition with a minimal/low risk of recurrence; additional evaluation/genetic testing during pregnancy not indicated); or "significant" (birth defect or genetic condition with an increased risk of recurrence; additional evaluation/genetic testing during the pregnancy indicated). About 72% (501/700) of the histories were negative, 19% (134/700) were positive, and about 9% (65/700) were significant. Among patients with significant family histories, 66% (n = 43) were women less than 35 years of age. We conclude that assessing a patient's family history at the time of first trimester serum screening is a valuable resource for pregnancy management.

Entities:  

Mesh:

Year:  2009        PMID: 19475500     DOI: 10.1007/s10897-009-9230-3

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  9 in total

1.  ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities.

Authors: 
Journal:  Obstet Gynecol       Date:  2007-01       Impact factor: 7.661

2.  Screening for Down syndrome: practice patterns and knowledge of obstetricians and gynecologists.

Authors:  Jane Cleary-Goldman; Maria A Morgan; Fergal D Malone; Julian N Robinson; Mary E D'Alton; Jay Schulkin
Journal:  Obstet Gynecol       Date:  2006-01       Impact factor: 7.661

3.  Genetic counseling before prenatal diagnosis for advanced maternal age: an important medical safeguard.

Authors:  S P Rubin; J Malin; J Maidman
Journal:  Obstet Gynecol       Date:  1983-08       Impact factor: 7.661

4.  First-trimester or second-trimester screening, or both, for Down's syndrome.

Authors:  Fergal D Malone; Jacob A Canick; Robert H Ball; David A Nyberg; Christine H Comstock; Radek Bukowski; Richard L Berkowitz; Susan J Gross; Lorraine Dugoff; Sabrina D Craigo; Ilan E Timor-Tritsch; Stephen R Carr; Honor M Wolfe; Kimberly Dukes; Diana W Bianchi; Alicja R Rudnicka; Allan K Hackshaw; Geralyn Lambert-Messerlian; Nicholas J Wald; Mary E D'Alton
Journal:  N Engl J Med       Date:  2005-11-10       Impact factor: 91.245

5.  The impact of first-trimester screening on AMA patients' uptake of invasive testing.

Authors:  Andrea M Wray; Alessandro Ghidini; Collette Alvis; Jonathan Hodor; Helain J Landy; Sarah H Poggi
Journal:  Prenat Diagn       Date:  2005-05       Impact factor: 3.050

6.  The practical importance of pedigree analysis in women considering invasive prenatal diagnosis for advanced maternal age or abnormal serum screening tests.

Authors:  D Meschede; S Albersmann; J Horst
Journal:  Prenat Diagn       Date:  2000-11       Impact factor: 3.050

7.  Impact of genetic counseling on primary and preventive care in obstetrics and gynecology.

Authors:  G M Cohn; R C Miller; M Gould; C J Macri; M L Gimovsky
Journal:  J Reprod Med       Date:  1999-01       Impact factor: 0.142

8.  The relevance of pre-amniocentesis pedigree analysis and genetic counseling.

Authors:  B Holzgreve; W Holzgreve; M S Golbus
Journal:  Clin Genet       Date:  1983-12       Impact factor: 4.438

9.  Construction of a family pedigree in genetic counseling before amniocentesis.

Authors:  A Langer; E Kudart
Journal:  J Reprod Med       Date:  1990-07       Impact factor: 0.142

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.